These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 167037)

  • 1. Somatic genetic analysis of cyclic AMP action: characterization of unresponsive mutants.
    Bourne HR; Coffino P; Tomkins GM
    J Cell Physiol; 1975 Jun; 85(3):611-20. PubMed ID: 167037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic genetic analysis of cyclic AMP action: selection of unresponsive mutants.
    Coffino P; Bourne HR; Tomkins GM
    J Cell Physiol; 1975 Jun; 85(3):603-10. PubMed ID: 167036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A variant of S49 mouse lymphoma cells with enhanced secretion of cyclic AMP.
    Steinberg RA; Steinberg MG; van Daalen Wetters T
    J Cell Physiol; 1979 Sep; 100(3):579-88. PubMed ID: 226556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth.
    Insel PA; Bourne HR; Coffino P; Tomkins GM
    Science; 1975 Nov; 190(4217):896-8. PubMed ID: 171770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of lymphoma cell death induced by cyclic AMP.
    Coffino P; Bourne HR; Tomkins GM
    Am J Pathol; 1975 Oct; 81(1):199-204. PubMed ID: 170834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B16 mouse melanoma cells selected for resistance to cyclic AMP-mediated growth inhibition are cross-resistant to retinoic acid-induced growth inhibition.
    Niles RM; Loewy B
    J Cell Physiol; 1991 Apr; 147(1):176-81. PubMed ID: 1645360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ornithine decarboxylase and S-adenosylmethionine decarboxylase activities of S49 lymphoma cells by agents increasing cyclic AMP.
    Honeysett JM; Insel PA
    J Cyclic Nucleotide Res; 1981; 7(5):321-32. PubMed ID: 6284819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple mechanisms of growth inhibition by cyclic AMP derivatives in rat GH1 pituitary cells: isolation of an adenylate cyclase-deficient variant.
    Martin TF; Ronning SA
    J Cell Physiol; 1981 Nov; 109(2):289-97. PubMed ID: 6271795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of cyclic AMP action: a genetic approach.
    Coffino P; Bourne HR; Friedrich U; Hochman J; Insel PA; Lemaire I; Melmon KL; Tomkins GM
    Recent Prog Horm Res; 1976; 32():669-84. PubMed ID: 183250
    [No Abstract]   [Full Text] [Related]  

  • 10. Dibutyryl cyclic AMP resistant MDCK cells in serum free medium have reduced cyclic AMP dependent protein kinase activity and a diminished effect of PGE1 on differentiated function.
    Devis PE; Grohol SH; Taub M
    J Cell Physiol; 1985 Oct; 125(1):23-35. PubMed ID: 2995425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
    Zaremba TG; Fishman PH
    Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hepatoma cell growth by analogs of adenosine and cyclic AMP and the influence of enzymes in mammalian sera.
    Hargrove JL; Granner DK
    J Cell Physiol; 1982 Jun; 111(3):232-8. PubMed ID: 6124549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of S49 lymphoma cell growth by cyclic adenosine 3':5'-monophosphate.
    Coffino P; Gray JW
    Cancer Res; 1978 Nov; 38(11 Pt 2):4285-8. PubMed ID: 212191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the PGE1 requirement for MDCK cell growth associated with a defect in cyclic AMP phosphodiesterase.
    Taub M; Saier MH; Chuman L; Hiller S
    J Cell Physiol; 1983 Feb; 114(2):153-61. PubMed ID: 6185509
    [No Abstract]   [Full Text] [Related]  

  • 15. beta Adrenergic receptor-mediated regulation of cyclic nucleotide phosphodiesterase in C6 glioma cells: vinblastine blockade of isoproterenol induction.
    Schwartz JP; Costa E
    J Pharmacol Exp Ther; 1980 Mar; 212(3):569-72. PubMed ID: 6244389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new principle for resistance to cholera: desensitization to cyclic AMP-mediated diarrhea induced by cholera toxin in the mouse intestine.
    Lönnroth I; Lange S
    J Cyclic Nucleotide Res; 1981; 7(4):247-57. PubMed ID: 6278008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by retinoic acid and cyclic adenosine 3':5'-monophosphate-inducing agents.
    Olsson IL; Breitman TR
    Cancer Res; 1982 Oct; 42(10):3924-7. PubMed ID: 6286100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexpression of mutant and wild type protein kinase in lymphoma cells resistant to dibutyryl cyclic AMP.
    Lemaire I; Coffino P
    J Cell Physiol; 1977 Sep; 92(3):437-45. PubMed ID: 198416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of phosphodiesterase and ornithine decarboxylase by cAMP is cell cycle independent.
    Kaiser N; Bourne HR; Insel PA; Coffino P
    J Cell Physiol; 1979 Dec; 101(3):369-74. PubMed ID: 231036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGE1-independent MDCK cells have elevated intracellular cyclic AMP but retain the growth stimulatory effects of glucagon and epidermal growth factor in serum-free medium.
    Taub M; Devis PE; Grohol SH
    J Cell Physiol; 1984 Jul; 120(1):19-28. PubMed ID: 6203919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.